Most remaining CCGs are authorised with conditionsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1916 (Published 21 March 2013) Cite this as: BMJ 2013;346:f1916
The final 48 clinical commissioning groups (CCGs) in England have been authorised by the NHS Commissioning Board, but it has imposed conditions on most.
A total of 211 CCGs have now been authorised to take on £65bn of the £95bn NHS commissioning budget from April this year. Overall, 43 (20%) of the 211 CCGs have been fully authorised, and 168 have been authorised with conditions. Fifteen of those authorised with conditions have also been issued with legal directions.123
Barbara Hakin, national director of commissioning development at the NHS Commissioning Board, said, “This is a tremendous achievement by CCGs, which have shown remarkable enthusiasm for—and commitment to—bringing the benefits of clinical commissioning to their local communities and are now on the threshold of taking up their new role. CCGs have made fantastic progress in a very short time.”
Of the 48 CCGs authorised in the fourth and final wave, only 10 met all 119 criteria to be fully authorised. Of the remaining 38, 31 did not meet all the authorisation criteria and were authorised with conditions that direct how they are to meet the remaining criteria.
Seven of the CCGs authorised with conditions have also been issued with legally binding directions that formalise the support they need to meet the conditions imposed on their authorisation.
The NHS Commissioning Board has said that it has always been clear that some CCGs would be at different stages from others, often on the basis of their previous commissioning activities, so would need support beyond authorisation. “CCGs will continue to receive this focused support from the NHS Commissioning Board, and we are confident that they will be able to further develop their capabilities within the coming months,” said Hakin.